AF
SGHT icon

Amalgamated Financial’s Sight Sciences SGHT Stock Holding History

Amalgamated Financial’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$31K Buy
+2,688
New +$41.4K ﹤0.01% 2609

Other funds holding SGHT

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Amalgamated Financial's SGHT Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Sight Sciences (SGHT) in Q1 2022: 2,688 shares worth $31K. The stake represents ﹤0.01% of the portfolio and ranks #2609 among its holdings.

66 funds tracked by Wall St. Rank hold SGHT as of Q1 2022.

  • Amalgamated Financial held 2,688 shares of Sight Sciences worth $31K as of Q1 2022.
  • Sight Sciences was a new Amalgamated Financial position in Q1 2022.
  • Sight Sciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2609 holding.
  • 66 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.